Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

ABSTRACT:

SUBMITTER: Merz M 

PROVIDER: S-EPMC5479613 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature